Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Desmond Mark Chapman has worked on the following 147 EPO patent applications which have been published in the last five years:

EP11787481

PENTOSE FERMENTATION BY A RECOMBINANT MICROORGANISM

IPC classification:
C07H 21/04, C12P 19/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11853018

NUCLEIC ACID SAMPLE PREPARATION METHODS AND COMPOSITIONS

IPC classification:
C12P 19/34
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11720696

POLYPEPTIDE INHIBITORS OF VLA4

IPC classification:
C07K 14/54
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12771485

ANTISENSE MODULATION OF PTP1B EXPRESSION

IPC classification:
C07H 21/04, C12N 15/113
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12773736

MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION

IPC classification:
C07H 21/02
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12776385

MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION

IPC classification:
A61K 31/7088, A61P 3/06
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11845186

INCREASING DRUG BIOAVAILABILITY IN NALTREXONE THERAPY

IPC classification:
A61K 31/137, A61K 31/485, A61P 3/04
Agent:
Zacco Denmark A/S
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12753889

GH61 GLYCOSIDE HYDROLASE PROTEIN VARIANTS AND COFACTORS THAT ENHANCE GH61 ACTIVITY

IPC classification:
C07H 21/00, C12N 9/42
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12829439

SAMPLE PREPARATION METHODS

IPC classification:
C07H 1/08, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12769209

BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF SUBSTITUTED LACTAMS

IPC classification:
C07K 14/435
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12834215

ANTISENSE MODULATION OF GCGR EXPRESSION

IPC classification:
A61P 3/08, A61P 3/10, A61P 7/12, C12N 15/113
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12833556

ENDOGLUCANASE 1B

IPC classification:
C12N 1/15, C12N 1/19, C12N 9/42, C12N 15/56, C12P 19/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11754012

PRODUCTION OF SINGLE-STRANDED CIRCULAR NUCLEIC ACID

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/66, C12P 19/34, C40B 40/08, C40B 50/06
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12843053

ANTISENSE MODULATION OF GCCR EXPRESSION

IPC classification:
C07H 21/04, C12N 5/00, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11766750

MODULATION OF CETP EXPRESSION

IPC classification:
C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP12847024

MODULATION OF TMPRSS6 EXPRESSION

IPC classification:
C07H 21/04, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12779771

MULTIPLE- ANALYTE ASSAY DEVICE AND SYSTEM

IPC classification:
B01L 3/00, C12M 1/34, G01N 27/327, G01N 35/00, G01N 35/10
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12795954

BIOCATALYSTS FOR THE PREPARATION OF HYDROXY SUBSTITUTED CARBAMATES

IPC classification:
C12N 9/00, C12N 9/04, C12P 7/00, C12P 13/00, C12P 17/10
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11744148

METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF DIFFERENT ANEUPLOIDIES IN A SAMPLE

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12859599

FATTY ALCOHOL FORMING ACYL REDUCTASE (FAR) VARIANTS AND METHODS OF USE

IPC classification:
C12N 1/21, C12N 9/02, C12N 15/53
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12859369

PRODUCTION OF SATURATED FATTY ALCOHOLS FROM ENGINEERED MICROORGANISMS

IPC classification:
C12P 7/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12859854

AMPLIFICATION PRIMERS AND METHODS

IPC classification:
C12P 19/34, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12859739

ENDOGLUCANASE 1B (EG1B) VARIANTS

IPC classification:
C12N 9/42
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12860563

METHODS FOR MODULATING METASTASIS-ASSOCIATED-IN-LUNG-ADENOCARCINOMA-TRANSCRIPT-1(MALAT-1) EXPRESSION

IPC classification:
A61K 38/28, C07H 21/02, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12862360

COMPOSITIONS AND METHODS FOR SAMPLE PREPARATION

IPC classification:
G01N 1/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP13741594

LOW DENSITY, HIGHLY POROUS NANO STRUCTURE

IPC classification:
A61K 49/06, B82B 1/00, B82B 3/00, C09K 11/02
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13743020

COMBINATION THERAPY COMPRISING A GROWTH HORMONE VARIANT AND AN OLIGONUCLEOTIDE TARGETED TO THE GROWTH HORMONE RECEPTOR

IPC classification:
A61K 31/7088, A61K 38/27, A61P 5/08
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13746752

MODULATION OF RNA BY REPEAT TARGETING

IPC classification:
C07H 21/04, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12776541

CELLOBIOHYDROLASE VARIANTS

IPC classification:
C12N 9/42, C12P 19/02, C12P 19/14
Applicant:
Shell Internationale Research Maatschappij B.V.
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Robert Maarten Matthezing, Shell International B.V.
Status:
EXAMINATION IN PROGRESS
EP11824373

METHOD FOR MOBILIZING STEM AND/OR PROGENITOR CELLS

IPC classification:
A61K 31/7125, A61P 43/00, C07H 21/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14177983

Chaperonin 10 immunosuppression

IPC classification:
A61K 38/17, A61P 37/06
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP12836344

FUNGAL PROTEASES

IPC classification:
C12N 1/15, C12N 9/20, C12N 9/24, C12N 9/48, C12N 9/58, C12N 15/57, C12P 19/02, C12P 19/14, C12P 21/00, C12P 21/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13767959

COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION FOR REDUCING SEIZURE AND MODIFYING A NEURODEGENERATIVE SYNDROME

IPC classification:
C07H 21/02, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP13720699

MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY

IPC classification:
A61K 31/712, A61P 13/12, A61P 35/00, A61P 43/00, C12N 15/113
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13724127

ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS

IPC classification:
C07K 14/435
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14192160

Simultaneous determination of aneuploidy and fetal fraction

IPC classification:
C12P 19/34, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13800883

METHODS OF TREATING OVERWEIGHT AND OBESITY

IPC classification:
A61K 31/22, A61K 31/24, A61K 31/335
Agent:
Zacco Denmark A/S
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13732008

PROSTATE-SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATES

IPC classification:
A61K 47/48
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13730786

ANTI-PSMA ANTIBODIES CONJUGATED TO NUCLEAR RECEPTOR LIGAND POLYPEPTIDES

IPC classification:
A61K 47/48, C07K 16/30
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP13732069

ANTI-CD70 ANTIBODY DRUG CONJUGATES

IPC classification:
A61K 47/48
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13817140

BIOREFINERY SYSTEM, METHODS AND COMPOSITIONS THEREOF

IPC classification:
C12N 1/21, C12N 15/63, C12P 7/64
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13823783

MODULATION OF RENIN-ANGIOTENSIN SYSTEM (RAS) RELATED DISEASES BY ANGIOTENSINOGEN

IPC classification:
C07H 21/02, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13836738

LENTIVIRAL VECTOR FOR STEM CELL GENE THERAPY OF SICKLE CELL DISEASE

IPC classification:
A61K 48/00, C12N 15/12, C12N 15/867
Applicant:
The Regents of the University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13841213

SWAB INTERFACE FOR A MICROFLUIDIC DEVICE

IPC classification:
A61B 10/02, C12M 1/30, G01N 1/02
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13844924

GAS-FED FERMENTATION SYSTEMS

IPC classification:
C12M 1/107, C12M 1/38
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13847099

METHODS FOR MONITORING C9ORF72 EXPRESSION

IPC classification:
C12N 5/00, C12N 5/071, C12N 15/11, C12Q 1/68
Applicant:
Johns Hopkins University
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13846202

METHODS OF TREATING KENNEDY'S DISEASE

IPC classification:
A61K 31/7088
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13777458

METHODS FOR TREATMENT OF ALPORT SYNDROME

IPC classification:
A61K 31/7125, A61P 13/12, C12N 15/113
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13846313

METHODS FOR MODULATING C9ORF72 EXPRESSION

IPC classification:
A61K 48/00, C12N 15/11
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
The Regents of the University of California
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11850991

GENE DISRUPTANTS PRODUCING FATTY ACYL-COA DERIVATIVES

IPC classification:
C12N 1/00, C12N 15/00, C12P 7/62
Applicant:
Shell Internationale Research Maatschappij B.V.
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Robert Maarten Matthezing, Shell International B.V.
Status:
The patent has been granted
EP13853782

COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF FATTY ACID DERIVATIVES

IPC classification:
C12N 1/20, C12P 7/64
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13864954

STABILIZED NANOPORE AND MICROPORE STRUCTURES AND METHODS FOR MAKING AND USING THE SAME

IPC classification:
C40B 40/04
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13864666

ENGINEERED BIOCATALYSTS AND METHODS FOR SYNTHESIZING CHIRAL AMINES

IPC classification:
C12N 9/10, C12N 15/54, C12N 15/63, C12P 13/00
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14737706

ENZYME PRODUCTION COMPOSITIONS AND METHODS

IPC classification:
C12P 7/14
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP15158571

Use of adipose tissue-derived stromal stem cells in treating fistula

IPC classification:
A61K 35/36, A61L 27/38, A61P 17/02, C12N 5/077
Applicant:
Universidad Autónoma de Madrid (UAM)
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11825969

STABILIZATION OF OZONE-LABILE FLUORESCENT DYES BY THIOUREA

IPC classification:
C07C 335/04, C09B 23/06, G01N 33/58
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14740809

ENGINEERED BIOCATALYSTS USEFUL FOR CARBAPENEM SYNTHESIS

IPC classification:
C12N 1/21
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14746677

METHODS, SYSTEMS, AND SOFTWARE FOR IDENTIFYING BIO-MOLECULES WITH INTERACTING COMPONENTS

IPC classification:
G06G 7/58
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14746406

METHODS, SYSTEMS, AND SOFTWARE FOR IDENTIFYING BIO-MOLECULES USING MODELS OF MULTIPLICATIVE FORM

IPC classification:
G01N 33/50
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP15175622

NONINVASIVE DIAGNOSIS OF FETAL ANEUPLOIDY BY SEQUENCING

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14757245

ENGINEERED TRANSAMINASE POLYPEPTIDES FOR INDUSTRIAL BIOCATALYSIS

IPC classification:
C12N 15/54
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14760467

LIPID BILAYER COATED MESOPOROUS SILICA NANOPARTICLES WITH A HIGH LOADING CAPACITY FOR ONE OR MORE ANTICANCER AGENTS

IPC classification:
A61K 9/127, A61K 9/16, A61K 47/02, A61P 35/00
Applicant:
The Regents of the University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Anton Hutter, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP14768515

HIGH-SPEED ON DEMAND MICROFLUIDIC DROPLET GENERATION AND MANIPULATION

IPC classification:
C12M 1/42, G01N 33/48, G01N 35/08
Applicant:
The Regents of the University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14717959

GENERATING CELL-FREE DNA LIBRARIES DIRECTLY FROM BLOOD

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14768844

NUCLEIC ACID CONTROL PANELS

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14772979

SYSTEMS AND METHODS FOR ISOLATING NUCLEIC ACIDS

IPC classification:
C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14768315

PHOTOCLEAVABLE DEOXYNUCLEOTIDES WITH HIGH-RESOLUTION CONTROL OF DEPROTECTION KINETICS

IPC classification:
C07H 21/04, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14769128

NUCLEOTIDE ANALOGS FOR SEQUENCING

IPC classification:
C07H 19/00, C07H 21/04, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14769114

BERAPROST ISOMER AS AGENT FOR THE TREATMENT OF VIRAL INFECTION

IPC classification:
A61K 31/343, A61K 31/5585, A61P 31/12, A61P 31/16
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP14773416

MULTIPLEX METHYLATION-SPECIFIC AMPLIFICATION SYSTEMS AND METHODS

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14791480

USE OF ANTI-CD47 AGENTS TO ENHANCE IMMUNIZATION

IPC classification:
C12N 5/10
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14762452

SDF-1 DELIVERY FOR TREATING ISCHEMIC TISSUE

IPC classification:
A61K 48/00, C07H 21/04, C12N 15/00
Applicant:
The Cleveland Clinic Foundation
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14791187

COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN (a) EXPRESSION

IPC classification:
A61K 48/00, C07K 14/775, C12N 15/113
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14768797

METHODS FOR ACHIEVING THERAPEUTICALLY EFFECTIVE DOSES OF ANTI-CD47 AGENTS

IPC classification:
C07K 16/28
Applicant:
Stanford University - Office of The General Counsel
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15177512

METHODS FOR MODULATING LIPOPROTEIN AND CHOLESTEROL LEVELS IN HUMANS

IPC classification:
A61K 48/00, A61P 3/06, C12N 15/11
Applicant:
Genzyme Corporation
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15192408

MODULATION OF FACTOR 7 EXPRESSION

IPC classification:
A61K 31/7088, A61P 7/02, A61P 35/00, C12N 15/113
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP15195673

NON-INVASIVE FETAL GENETIC SCREENING BY DIGITAL ANALYSIS

IPC classification:
C12P 19/34, C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP15189401

MODULATION OF APOLIPOPROTEIN C-III EXPRESSION

IPC classification:
A61K 31/00
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP15196275

HLA-RESTRICTED, PEPTIDE-SPECIFIC ANTIGEN BINDING PROTEINS

IPC classification:
A61K 39/395, C07K 16/08, C07K 16/18, C07K 16/28
Applicant:
Memorial Sloan Kettering Cancer Center
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15181244

METHODS FOR DETERMINING FRACTION OF FETAL NUCLEIC ACIDS IN MATERNAL SAMPLES

IPC classification:
C12P 19/34, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14739612

METHOD FOR DETERMINING COPY NUMBER VARIATIONS IN SEX CHROMOSOMES

IPC classification:
C12Q 1/68, G06F 19/24
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14737468

COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF LACTATE FROM C1 COMPOUNDS USING LACTATE DEHYDROGENASE TRANSFORMANTS

IPC classification:
C12N 9/04, C12P 7/56
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14820178

METHOD FOR THE PURIFICATION OF TARGETED NUCLEIC ACIDS FROM BACKGROUND NUCLEIC ACIDS

IPC classification:
C12N 15/10
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP15199731

METHOD OF SYNTHESIZING POLYNUCLEOTIDE VARIANTS

IPC classification:
C07H 21/00, C12N 15/10, C12N 15/11, C12Q 1/68, C40B 40/06, C40B 50/06
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11829931

USE OF AN ENDOGENOUS 2-MICRON YEAST PLASMID FOR GENE OVER EXPRESSION

IPC classification:
C12N 15/66, C12N 15/81
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14772484

PRODUCTION OF 1,6-HEXANEDIOL FROM ADIPIC ACID

IPC classification:
B01J 23/42, C07C 29/149
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14761937

MASSIVELY PARALLEL SINGLE CELL ANALYSIS

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14839126

METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE AND DISC TISSUE PATHOLOGIES

IPC classification:
A61K 35/32, A61K 38/17, A61K 47/36, A61P 19/00, A61P 19/02, C07K 7/06, C07K 7/08, C12N 5/077, C12N 5/10, C12N 15/11
Applicant:
McGill University - The Royal Institution for the Advancement of Learning
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP15198767

MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS

IPC classification:
A61K 39/00, C07K 16/28, C07K 16/30, C12N 5/00, C12N 5/09, C12Q 1/68, G01N 33/50, G01N 33/574
Applicant:
Stanford University - Office of The General Counsel
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11797388

TREATMENT OF PROLIFERATIVE DISEASES

IPC classification:
A61K 38/16, A61P 35/00, G01N 33/50
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14845184

MODULATION OF EFFEROCYTOSIS PATHWAYS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE

IPC classification:
A61P 9/10
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14781426

AUTOMATED SCREENING OF ENZYME VARIANTS

IPC classification:
G06F 19/00, G06F 19/16
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14786396

STRUCTURE BASED PREDICTIVE MODELING

IPC classification:
G06F 19/16
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP16160470

METHODS FOR MANIPULATING PHAGOCYTOSIS MEDIATED BY CD47

IPC classification:
A61K 39/00, A61K 39/395, A61K 47/48, C07K 16/18, C07K 16/28, C07K 16/30, C07K 16/46
Applicant:
Stanford University - Office of The General Counsel
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14786757

METHODS AND SYSTEMS FOR DIGITALLY COUNTING FEATURES ON ARRAYS

IPC classification:
G01N 21/27, G01N 21/64
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP16160476

METHODS FOR MANIPULATING PHAGOCYTOSIS MEDIATED BY CD47

IPC classification:
A61K 39/00, A61K 39/395, A61K 47/48, C07K 16/18, C07K 16/28, C07K 16/30, C07K 16/46
Applicant:
Stanford University - Office of The General Counsel
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14854442

METHODS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT

IPC classification:
A61K 38/00, C07H 21/04, C12N 15/11
Applicant:
The Regents of the University of California
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14854291

COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT

IPC classification:
C07H 21/04, C12N 15/11
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14854819

NUCLEOSIDE SUPPLEMENTATION TO PROMOTE CELLULAR FUNCTION, GENETIC STABILITY AND REGENERATIVE APPLICATIONS

IPC classification:
C12N 5/02, C12N 5/074
Applicant:
The Regents of the University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14796611

METHOD FOR IMPROVING THE SENSITIVITY OF DETECTION IN DETERMINING COPY NUMBER VARIATIONS

IPC classification:
G06F 19/20, G06F 19/22
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14802966

MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY

IPC classification:
C12N 15/113
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11778262

BIOCATALYSTS FOR EZETIMIBE SYNTHESIS

IPC classification:
A61K 38/16, C07K 1/00
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11761888

MACROCYCLIC LACTONE RESISTANCE MARKER FOR DIROFILARIA IMMITIS

IPC classification:
C07H 21/04, C07K 14/435, C12N 15/12, C12Q 1/68
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
David Richard Spinner, Greaves Brewster LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14860658

TARGETED SCREENING FOR MUTATIONS

IPC classification:
C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP12183946

Noninvasive diagnosis of fetal aneuploidy by sequencing

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
PATENT GRANTED
EP14862555

ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS

IPC classification:
C07K 14/305
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11838704

COMPOSITIONS AND METHODS FOR PRODUCTION OF FERMENTABLE SUGARS

IPC classification:
C12N 1/15, C12N 1/22, C12N 9/04, C12N 9/42, C12P 7/10, C12P 19/02, C12P 19/12, C12P 19/14, C13K 1/02
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14867191

COMPOSITIONS AND METHODS FOR REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS

IPC classification:
A61K 31/137, A61K 31/485, A61P 3/04
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16158103

RESOLVING GENOME FRACTIONS USING POLYMORPHISM COUNTS

IPC classification:
C12Q 1/68, G06F 19/18, G06F 19/22, G06F 19/24
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14874081

MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION

IPC classification:
C12N 15/113
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15737349

MICROORGANISMS FOR THE ENHANCED PRODUCTION OF AMINO ACIDS AND RELATED METHODS

IPC classification:
C12N 1/21, C12P 13/04, C12P 13/08, C12P 13/12, C12P 13/22
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15737403

CARBOHYDRATE-ENRICHED RECOMBINANT MICROORGANISMS

IPC classification:
C12N 1/21, C12N 9/88, A23K 50/00, A23K 10/40
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16163920

MODIFIED LEPTIN POLYPEPTIDES AND THEIR USES

IPC classification:
C07H 21/04, C07K 14/00, C07K 14/575, C12P 21/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15746681

CELL MODULATION NANOCOMPOSITION, AND METHODS OF USE

IPC classification:
B82B 1/00, C07K 14/705, C07K 14/725, C12N 5/02, C12N 5/0783, G01N 33/58
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15711627

DISPOSABLE, INTEGRATED MICROFLUIDIC CARTRIDGE AND METHODS OF MAKING AND USING SAME

IPC classification:
B01L 3/00, B01L 7/00
Applicant:
Illumina, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15764889

GENOME EDITING WITHOUT NUCLEASES

IPC classification:
C12N 15/85
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15769138

EFFICIENT DELIVERY OF LARGE CARGOS INTO CELLS ON A POROUS SUBSTRATE

IPC classification:
C12N 1/15, C12N 1/19, C12N 5/071, C12N 15/87
Applicant:
The Regents of the University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16179626

COMPOSITION AND METHODS FOR INCREASING INSULIN SENSITIVITY

IPC classification:
A61K 31/00, A61K 31/135, A61K 31/138, A61K 31/423, A61K 31/4525, A61K 31/485, A61K 31/55, A61K 31/551, A61K 31/7048, A61K 45/06, A61P 3/10
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP16194186

COMPOSITIONS AND METHODS FOR SAMPLE PREPARATION

IPC classification:
C12N 15/10, G01N 1/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP15726809

METHODS FOR BIOLOGICAL PRODUCTION OF VERY LONG CARBON CHAIN COMPOUNDS

IPC classification:
C12N 1/21, C12P 7/64
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15793647

METHOD TO CONCENTRATE APOA-I MIMETIC PEPTIDES TRANSGENICALLY EXPRESSED IN PLANTS

IPC classification:
A61K 38/00, A61K 38/10, A61P 35/00, C07K 1/14, C07K 7/08, C07K 14/775
Applicant:
The Regents of the University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15779558

ENGINEERED TYROSINE AMMONIA LYASE

IPC classification:
A61K 38/51, C12N 9/88
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15728356

DETECTING FETAL SUB-CHROMOSOMAL ANEUPLOIDIES AND COPY NUMBER VARIATIONS

IPC classification:
C12Q 1/68, G06F 19/20
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16199980

CELLS FOR USE IN A METHOD FOR TREATING INFLAMMATORY DISORDERS

IPC classification:
C12N 5/077, C12N 5/0775, C12N 5/0783
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP15742101

MESENCHYMAL STROMAL CELLS FOR TREATING RHEUMATOID ARTHRITIS

IPC classification:
A61K 35/28, A61P 9/02
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15742102

MESENCHYMAL STROMAL CELLS FOR TREATING SEPSIS

IPC classification:
A61K 35/28, A61P 31/00
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15818953

NOVEL P450-BM3 VARIANTS WITH IMPROVED ACTIVITY

IPC classification:
C07H 21/04, C07K 14/00, C12N 1/20, C12N 9/02, C12N 15/00
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16188163

COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES

IPC classification:
A61K 31/337, A61K 31/427, A61K 39/00, A61K 39/395, A61P 35/00, C07D 207/325, C07D 401/12, C07D 417/12, C07K 5/02, C07K 5/06, C07K 16/28
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP16194174

SAMPLE PREPARATION METHODS

IPC classification:
C07H 1/08, C12N 15/10, C12Q 1/68
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP15750573

TARGETING MICRORNAS FOR METABOLIC DISORDERS

IPC classification:
A61K 31/712, C07H 21/00, C12N 15/113
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP17154000

QUANTITATING HIGH TITER SAMPLES BY DIGITAL PCR

IPC classification:
C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP15831906

MULTIFUNCTIONAL OLIGONUCLEOTIDES

IPC classification:
C12Q 1/68, C40B 30/04, C40B 40/06
Applicant:
Abbott Molecular Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15832024

LIBRARY GENERATION FOR NEXT-GENERATION SEQUENCING

IPC classification:
C12N 15/10, C12Q 1/68
Applicant:
Abbott Molecular Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16200105

HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/46, C12N 5/07, C12N 5/16, C12P 21/08, G01N 33/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
APPLICATION PUBLISHED
EP15834442

APOE4-TARGETED THERAPUTICS THAT INCREASE SIRT1

IPC classification:
A61K 31/16, A61K 31/165, A61P 25/28, C07C 219/10, C07C 219/14
Applicant:
The Regents of the University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15836264

METHODS OF FABRICATING A MULTI-ELECTRODE ARRAY FOR SPINAL CORD EPIDURAL STIMULATION

IPC classification:
A61N 1/05, A61N 1/18
Applicant:
The Regents of the University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15836927

MULTI-ELECTRODE ARRAY FOR SPINAL CORD EPIDURAL STIMULATION

IPC classification:
A61N 1/04, A61N 1/05
Applicant:
The Regents of the University of California
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15835482

ENGRAFTMENT OF STEM CELLS WITH A COMBINATION OF AN AGENT THAT TARGETS STEM CELLS AND MODULATION OF IMMUNOREGULATORY SIGNALING

IPC classification:
A61K 39/395, C07K 16/30, C12Q 1/68
Applicant:
Stanford University - Office of The General Counsel
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16201269

IMPROVED LOV-D ACYLTRANSFERASE MEDIATED ACYLATION

IPC classification:
C07K 14/00, C12N 9/10, C12P 7/00
Applicant:
Codexis, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
The application has been published
EP15771527

DETECTING REPEAT EXPANSIONS WITH SHORT READ SEQUENCING DATA

IPC classification:
G06F 19/18
Applicant:
Illumina Cambridge Ltd
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15842185

ANTISENSE COMPOUNDS AND USES THEREOF

IPC classification:
C12N 15/00, C12N 15/113
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15841383

TARGETING ANEURYSM DISEASE BY MODULATING PHAGOCYTOSIS PATHWAYS

IPC classification:
A61P 9/10
Applicant:
Stanford University - Office of The General Counsel
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15841893

SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS

IPC classification:
C07K 1/04, C40B 60/14
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15842825

ANTISENSE COMPOUNDS AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16205580

USING CELL-FREE DNA FRAGMENT SIZE TO DETERMINE COPY NUMBER VARIATIONS

IPC classification:
C12Q 1/68, G06F 19/00, G06F 19/18, G06F 19/22, G06F 19/24
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Status:
Examination is in progress

Please Sign in to use this feature